ADVERTISEMENT
Search

 

Press Releases

 

FDA’s Decision to Block Pharmacists from Ordering COVID-19 Oral Antivirals Will Hurt COVID Positive Patients, National Pharmacy Groups Warn Read more

FDA’s Decision to Block Pharmacists from Ordering COVID-19 Oral Antivirals Will Hurt COVID Positive Patients, National Pharmacy Groups Warn

The American Pharmacists Association (APhA), American Society of Consultant Pharmacists (ASCP), American Society of Health System Pharmacists (ASHP), National Alliance of State Pharmacy Associations (NASPA), and the National Community Pharmacists Association (NCPA) today issued the following statement in response to the FDA’s decision to authorize the Pfizer COVID-19 oral antiviral but specifically prevent pharmacists from writing the prescriptions:

RSS